Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
about
(E)-5-(2-Bromovinyl)-2'-deoxyuridine: a potent and selective anti-herpes agentAcyclovir inhibition of Epstein-Barr virus replication9-(3,4-dihydroxybutyl)guanine, a new inhibitor of herpesvirus multiplicationComparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in miceErythro-9-(2-hydroxy-3-nonyl) Adenine alone and in combination with 9-beta-D-arabinofuranosyladenine in treatment of systemic herpesvirus infections in miceTetrahydrouridine specifically facilitates deoxycytidine incorporation into herpes simplex virus DNAHerpes simplex virus mutants resistant to arabinosyladenine in the presence of deoxycoformycinInhibition of mouse LM cell replication by trifluorothymidine: role of cytosolic deoxythymidine kinase.Regulation of Adenosine Deaminase on Induced Mouse Experimental Autoimmune Uveitis.Inhibitors of adenosine deaminase and the development of antiviral agents.The nucleoside antagonist cordycepin causes DNA double strand breaks in breast cancer cells.Inhibition of herpes simplex virus-induced DNA polymerase activity and viral DNA replication by 9-(2-hydroxyethoxymethyl)guanine and its triphosphate.Inhibition of adenosine deaminase (ADA)-mediated metabolism of cordycepin by natural substances.Inactivation of liver S-adenosylhomocysteine hydrolase in vitro of rats treated with erythro-9-(2-hydroxynon-3-yl)adenine.Inhibition of lymphocyte-mediated cytolysis and cyclic AMP phosphodiesterase by erythro-9-(2-hydroxy-3-nonyl)adenine.Activity of AMP against experimental herpes simplex virus type 1 infections in mice.
P2860
Q28322607-4D63DD91-ECD0-49FE-9F7D-F8A1CA5155D1Q28366051-EE6A2FEA-F84B-40FC-B79A-A252F45BFC4EQ28366251-F68BE2AE-50EE-410E-A182-EFE6ABC89E88Q28366970-5C5BF24A-7D0F-48CF-99B4-C3D0153A2A5EQ33735012-60F55A1C-1251-4549-A28C-EC8CA7AE29EFQ35236445-616D06CA-06C3-4BF5-A148-BD7075EB25DFQ35568390-F8FC9BCA-B948-44A8-9FBB-FC6A0C89BD4DQ35669956-290EC01C-3048-4B06-BDC7-CD1FAA2B4E87Q36655815-3269F8CB-408D-4C5C-BF4C-F6AC7F2EFFA7Q38155767-0C4620AB-E004-43E5-8F3A-912D494A3911Q39310326-522464B0-E4D0-4769-A0DD-B11B0F5F7F6DQ40292914-2B756C53-49E8-4E79-9462-8CF26B3951B6Q41370095-C5FA3029-07D5-417B-8338-80B2115CC014Q41953533-36A9A8FB-7CE4-403A-B917-B692E31BD537Q42452659-B142FC40-5E1D-4CC4-BFEF-4C8FB6B6D6E1Q42930323-1E49FADA-43E1-42E2-9B70-7B199BAE3861
P2860
Erythro-9-(2-hydroxy-3-nonyl)adenine as a specific inhibitor of herpes simplex virus replication in the presence and absence of adenosine analogues.
description
1978 nî lūn-bûn
@nan
1978年の論文
@ja
1978年論文
@yue
1978年論文
@zh-hant
1978年論文
@zh-hk
1978年論文
@zh-mo
1978年論文
@zh-tw
1978年论文
@wuu
1978年论文
@zh
1978年论文
@zh-cn
name
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@ast
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@en
type
label
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@ast
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@en
prefLabel
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@ast
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@en
P2860
P356
P1476
Erythro-9-(2-hydroxy-3-nonyl)a ...... bsence of adenosine analogues.
@en
P2093
P2860
P304
P356
10.1073/PNAS.75.10.4684
P407
P577
1978-10-01T00:00:00Z